Hearth Record

Morton Plant Hospital

An acute care hospital in Clearwater, Florida 33756

300 Pinellas St, Clearwater, Florida 33756. (727) 462-7000.

CMS’s own record, on Care Compare

Watch and the shortlist are kept with a free account, on every device. Your watch list. CMS’s own record is on Care Compare.

The short answer

Record last released by CMS on Oct 20, 2026.

The last 24 months 2 deficiencies in 1 month of the last 36. Last cited May 2026. Most serious: Standard-level. Every month

Each figure’s source sits beside it, in its section below.

What these words mean3
Star ratings
CMS rates some kinds of place from 1 to 5 stars, more stars meaning better on CMS’s own measures for that kind: for a nursing home, its health inspections, staffing and quality measures. A rating is CMS’s summary of those measures; it doesn’t promise good care. Source: CMS, Care Compare and the Five-Star Quality Rating System.
Inspection (survey)
A visit by state inspectors, often unannounced, who check a place against the rules it must meet. For nursing homes and other places Medicare pays, CMS calls these visits surveys: a standard survey of a nursing home comes at least every 15 months, and a complaint survey whenever a complaint calls for one. Source: CMS; 42 CFR 488.308.
Deficiency, citation, violation
What inspectors write up when a place didn’t meet a rule: the rule, what they saw, and when. CMS calls it a deficiency; states may say citation or violation. It is the inspectors’ finding, not a court’s, and the place is usually asked for a plan to correct it. Source: CMS, statement of deficiencies (Form CMS-2567); each state’s licensing agency.

What did inspectors find?

The last inspection on record was on May 11, 2026: a complaint inspection.

2 deficiencies cited in the last three years.

Source:

CMS, QCOR Hospital 2567 statements of deficiencies. Released Oct 20, 2026. Updated monthly.

When those deficiencies happened

2 deficiencies in 1 month of the last 36. Last cited May 2026. Most serious: Standard-level. The last 3 years, to Nov 5, 2026.

2 deficiencies by month over the last 3 years. Each cell is one month.
JanFebMarAprMayJunJulAugSepOctNovDec
2023 Dec
2024 JanFebMarAprMayJunJulAugSepOctNovDec
2025 JanFebMarAprMayJunJulAugSepOctNovDec
2026 JanFebMarAprMayJunJulAugSepOctNov

Hover or focus a month to read it.

No visit on record Visited, nothing cited A stronger orange is more serious, on its source’s own levels, read onto four bands: from the least serious it publishes to the most
Source:

Hearth Record drew this from the dates and levels in the source’s own records.

Each deficiency, as cited

Rule titles as CMS’s inspectors cite them, set in sentence case.

Source:

CMS, QCOR Hospital 2567 statements of deficiencies. Released Oct 20, 2026. Updated monthly.

May 11, 2026: complaint inspection2 deficiencies
  • Patient Rights: Care In Safe Setting

    The inspectors’ words, 2,009 words

    “PATIENT RIGHTS: CARE IN SAFE SETTING CFR(s): 482.13(c)(2) The patient has the right to receive care in a safe setting. This Standard is not met as evidenced by: 48190 Based on the facility’s policy and protocol, medical record review and interviews, the facility failed to ensure care was provided in a safe setting. The facility did not adhere to their protocol administration of Pitocin (medication used by medical professionals to induce labor, strengthen weak contractions, manage miscarriages, or control heavy bleeding immediately after childbirth) and recognize fatal changes in fetal heart monitoring for 1 (Patient #1) of 1 patient sampled, resulting in the demise of Patient #2. Findings included: Review of facility policy, “Labor and Birth, care of the Patient During” last revised 09/2025 revealed: Expected Outcome: 1. Maternal/ fetal well- being is optimized during labor and birth 2. Parent’s birth experience is reflective of their personnel goals and individual 3. Fetal well-being is assessed, and any fetal compromise is identified. Potential Complications: 1. Category 2 (It indicates that the fetus might be experiencing stress or a temporary lack of oxygen, requiring close monitoring and potential, though not immediate, intervention) or Category 3 (is an abnormal intrapartum tracing. It indicates significant fetal stress, risk of fetal acidemia (low pH), and potential for hypoxic-ischemic encephalopathy. These patterns require immediate clinical evaluation and interventions) FHR pattern. 2. Tachysystole (greater than 5 contractions in a 10-minute window averaged over 30 minutes) ... Safety Care: Use continuous fetal monitoring in the following situations: Category 2 or Category 3 pattern and administration of any medication which may affect FHR pattern (induction/augmentation agents). Category 2: minimal variability (it may point to fetal stress, oxygen deprivation, or the effects of medication), absent variability with no decelerations (indicates the heart rate stays completely flat, typically lacking both natural fluctuations and drops), accelerations (temporary, abrupt increases in the baby’s heart rate above the baseline), variable decelerations with minimal variability (minimal variability may suggest fetal stress or hypoxia, requiring close monitoring and immediate in-utero resuscitation by your healthcare team), recurrent late decelerations with moderate variability (fetus is experiencing placental insufficiency; reduced blood/oxygen flow) Category 3: absent variability recurrent late decelerations (placental insufficiency causing fetal hypoxia and acidosis. This finding requires immediate, urgent medical intervention to resuscitate the fetus and assess the need for expedited delivery), recurrent variable decelerations (abrupt decreases in a baby’s heart rate that limit the baby’s oxygen supply. When frequent, they are considered a concerning pattern that requires careful monitoring and immediate clinical intervention) Review of the Pitocin protocol revealed: 1. Titration instructions: a. Starting rate 2 milliunits/minute b. titrate by 2 milliunits/minute every 30 minutes until adequate uterine activity (contractions 3 to 5 minutes apart, palpate matter moderate or 50/60 MMHG above resting tone by uterine pressure catheter intensity) c. contact provider if the rate of 20 milliunits/minute is reached. d. Maximum dose 42 milliunits/minute. 2. Uterine tachysystole or unresolved category 2 fetal tracing: a. decrease Pitocin to half of the current rate for 15 minutes. b. If uterine tachysystole or category 2 tracing is not resolved discontinue Oxytocin (Pitocin). c. Notify physician. 3. Category 3 fetal tracing or prolonged deceleration: a. discontinue Pitocin b. notify physician 4. if fetal tracing resolves: a. if Pitocin infusion held less than or equal to 30 minutes restart oxytocin at half of the previous rate b. if Pitocin infusion held greater than 30 minutes restart at the initial order rate. Review of Patient #1’s medical record showed that Patient #1 was admitted on 04/20/2026 at 6:39 PM for a scheduled induction of labor. Pitocin was initiated on 04/21/2026 at 10:00 PM and intermittently stopped overnight due to late fetal heart rate decelerations. On 04/22/2026 at 11:37 AM, the patient was noted to be fully dilated, 100% effaced, and +1 station, and pushing began. Intermittent variable and late decelerations occurred during pushing but resolved with maternal repositioning, with baseline FHR remaining approximately 150 bpm. The physician discussed vacuum assisted delivery multiple times, including at 12:44 PM, but determined at that time that fetal descent was insufficient for safe vacuum use. At approximately 14:00, decelerations reached nadirs in the 40-50’s for the first time, and the fetus was at +3 station with crowning. Due to significant caput but adequate ability to place the vacuum safely, the physician proceeded with vacuum assisted vaginal delivery as the most expeditious option. Vacuum assistance occurred over four contractions. The infant was delivered but was nonresponsive with no cry at birth; the cord was immediately clamped and cut, and the infant was transferred to the NICU (Neonatal Intensive Care Unit) team, who had been present during the final pushing efforts. The baby expired after resuscitative efforts failed. During review of the fetal heart monitoring strips for Patient #1 on 5/11/2026 at 12:00 PM, the Evidence Based Quality Coordinator (EBQC) stated regarding 04/22/2026 at 10:00 AM, the fetal heart monitoring strip showed minimal variability with no accelerations (abrupt, temporary increases in the baby’s heart rate above the baseline considered a reassuring sign that the fetus is healthy, well-oxygenated, and has a properly functioning nervous system), and the Pitocin was increased from 8 units to 10 units. At 10:30 AM, the fetal heart monitoring strip showed minimal variability, accelerations were absent, late and variable decelerations (specific patterns in a baby’s heart rate observed during electronic fetal monitoring during labor. They represent different underlying issues and require specific medical interventions) are present, and the Pitocin was increased from 10 units to 12 units. At 11:00 AM, the fetal heart monitoring strip showed minimal variability, accelerations are absent, late and variable decelerations are present, and the Pitocin was increased from 12 units to 14 units. At 12:00 PM, the fetal heart monitoring strip showed absent variability, accelerations are absent, late and variable decelerations are present; the Pitocin is still infusing. The EBQC stated that the nurses charting was not appropriate, and the use of Pitocin was not appropriate. The bedside nurse had fetal monitoring education and should be competent in reading an electronic fetal monitoring strip. She should be able to tell if a baby is in distress. Based on review of the strip, they did not follow the protocol. During an interview on 05/11/2026 at 9:36 AM, the Risk Manager stated no one identified the strip (fetal heart monitoring) looked bad, the strip prior looked ok. There were some variability (fluctuations in the baseline heart rate) and some variables (decelerations). Not repetitive late decelerations variability during pushing more repetitive variable (how well the baby is tolerating the physical stress of delivery). The MD (Medical Doctor) was at the bedside the whole time. The patient was not listening to be able to pause and check heart rate; that’s where the problem was. The patient was pushing with and without contractions so they could not make sense of the pattern due to her pushing constantly. The MD told me she felt the pattern was not unusual and often returned to baseline. The MD found it hard to define a moment where she would change the management of the patient. The case was sent for per review, and opportunities were identified and are being addressed. During an interview on 05/11/2026 at 1:34 PM, Patient #1’s beside RN (Registered Nurse) stated the MD ordered to start a low dose Pitocin and she said I’ll be back in two hour; there was a couple times baby heart rate went down, and we repositioned mom then baby heart rate came right back up. Mom was complete and MD said let’s start pushing, so we started pushing. The babies’ heart rate kept going down and the patient was getting erratic. After an hour, I asked the MD if she was progressing and the MD said yes to continue pushing. The MD educated mom on using the vacuum (a procedure used during the second stage of labor. A doctor attaches a soft, plastic suction cup to the baby’s head to gently guide the baby through the birth canal while the mother pushes) to assist with the delivery. I’ve never had a provider use the vacuum that long. The patient was just screaming. There are a lot of things I forgot to document looking back on the incident. At one point, the MD said to continue pushing and she was stepping out to check on another patient. I was not comfortable with that, so I went to get her and to tell her to come back and she needs to stay. My charge nurse was aware of the situation; she was there at that point. A lot of people were in the room because the fetal heart strip (continuous visual record of a baby’s heart rate alongside the mother’s uterine contractions) looked bad meaning the baby’s heart rate kept dropping to the 90’s. Looking back on the situation, I should have gone to get another MD to help after the 1st hour of pushing and the frequent decelerations that were occurring. During an interview on 05/11/2026 at 2:12 PM, the MD stated when I did my morning rounds, Patient #1 was still 6 centimeters and I said increase her Pitocin and if she’s not able to progress then I plan on doing a C section (a surgical procedure used to deliver a baby through incisions in the mother’s abdomen and uterus). She made progress and she had some intermittent (stops and starts at irregular intervals) decelerations throughout the day but always responded when we put her in different positions. I think the patient was completely dilated (cervix opened to 10 centimeters, allowing enough room for the baby’s head and shoulders to pass through the birth canal.) at 11:30 am and started pushing. There was a period when she requested I help her while she pushed. There was a brief period when I was out of the room, and I checked on the other laborers. She was pushing well and then she had a very deep variable that went to the 40’s and then the heart rate came immediately back up to the 150’s but without much variability at all, very minimal. When it did that again it was down for 30 seconds or less. Then the next one was similar maybe 30 to a minute. The patient kept saying can you please help me? Can you do something to help me get this baby out faster? The MD stated it was not worth the risks of a vacuum at that point at which she was requesting help. Then, she had that really deep variable (deceleration) and if I had tried to do a section (surgical birth), I was really concerned the baby would be wedged down the pelvis and I would have a very difficult extraction, or it would take longer like getting to the OR (operating room). I have never used a vacuum in my career. There were times when the baby had late decelerations but felt the baby was safe to be delivered vaginally. She stated she thought it was more cord compression during that time. The Pitocin was not turned off because she was progressing, the baby was responding to position changes, and the baby did not show signs of distress for longer than 1 minute. We have a meeting coming up for women’s clinical institution and category 2 algorithms will be discussed. I’m not sure if we are discussing that because of the incident. During an interview on 05/11/2026 at 2:39 PM while reviewing the fetal heart monitoring strips, the Director of Women’s Services, who is certified in electronic fetal monitoring, stated based on the protocols I would not have increased the Pitocin. The charting does not look accurate. The Pitocin should have been turned off. During an interview on 05/11/2026 at 3:39 PM, the CMO (Chief Medical Officer) stated during the peer review, it was identified that there were opportunities for strip interpretation and interventions that were not done. Until more discussions, the MD will not be able to practice here or at [another hospital name] until more discussions can take place.”

    Rule A0144. Standard-level. From a complaint.

  • Medical Staff Bylaws

    The inspectors’ words, 1,947 words

    “MEDICAL STAFF BYLAWS CFR(s): 482.22(c) The medical staff must adopt and enforce bylaws to carry out its responsibilities. The bylaws must: This Standard is not met as evidenced by: 48190 Based on medical record review, facility policy/protocols and interviews, the physician failed to identify and act upon a possible fatal fetal heart rate and follow hospital protocols for Pitocin administration in 1 (Patient #1) of 1 patient sampled, associated with the death of Patient #2. Findings included: Review of facility policy, “Labor and Birth, care of the Patient During” last revised 09/2025 revealed: Expected Outcome: 1. Maternal/ fetal well- being is optimized during labor and birth 2. Parent’s birth experience is reflective of their personnel goals and individual 3. Fetal well-being is assessed, and any fetal compromised is identified. Potential Complications: 1. Category 2 (It indicates that the fetus might be experiencing stress or a temporary lack of oxygen, requiring close monitoring and potential, though not immediate, intervention) or Category 3 (is an abnormal intrapartum tracing. It indicates significant fetal stress, risk of fetal acidemia (low pH), and potential for hypoxic-ischemic encephalopathy. These patterns require immediate clinical evaluation and interventions) FHR pattern 2. Tachysystole (greater than 5 contractions in a 10-minute window averaged over 30 minutes) ... Safety Care: Use continuous fetal monitoring in the following situations: Category 2 or Category 3 pattern and administration of any medication which may affect FHR pattern (induction/augmentation agents). Category 2: minimal variability (it may point to fetal stress, oxygen deprivation, or the effects of medication), absent variability with no decelerations (indicates the heart rate stays completely flat, typically lacking both natural fluctuations and drops), accelerations (temporary, abrupt increases in the baby’s heart rate above the baseline), variable decelerations with minimal variability (minimal variability may suggest fetal stress or hypoxia, requiring close monitoring and immediate in-utero resuscitation by your healthcare team), recurrent late decelerations with moderate variability (fetus is experiencing placental insufficiency; reduced blood/oxygen flow) Category 3: absent variability recurrent late decelerations (placental insufficiency causing fetal hypoxia and acidosis. This finding requires immediate, urgent medical intervention to resuscitate the fetus and assess the need for expedited delivery), recurrent variable decelerations (abrupt decreases in a baby’s heart rate that limit the baby’s oxygen supply. When frequent, they are considered a concerning pattern that requires careful monitoring and immediate clinical intervention) Review of the Pitocin protocol revealed: 1. Titration instructions: a. Starting rate 2 milliunits/minute b. titrate by 2 milliunits/minute every 30 minutes until adequate uterine activity (contractions 3 to 5 minutes apart, palpate matter moderate or 50/60 MMHG above resting tone by uterine pressure catheter intensity) c. contact provider if the rate of 20 milliunits/minute is reached. d. Maximum dose 42 milliunits/minute. 2. Uterine tachysystole or unresolved category 2 fetal tracing: a. decrease Pitocin to half of the current rate for 15 minutes. b. If uterine tachysystole or category 2 tracing is not resolved discontinue oxytocin. c. Notify physician. 3. Category 3 fetal tracing or prolonged deceleration: a. discontinue Pitocin b. notify physician 4. if fetal tracing resolves: a. if Pitocin infusion held less than or equal to 30 minutes restart oxytocin at half of the previous rate b. if Pitocin infusion held greater than 30 minutes restart at the initial order rate. Review of Patient #1’s medical record showed that Patient #1 was admitted on 04/20/2026 at 6:39 PM for a scheduled induction of labor. Pitocin was initiated on 04/21/2026 at 10:00 PM and intermittently stopped overnight due to late fetal heart rate decelerations. On 04/22/2026 at 11:37 AM, the patient was noted to be fully dilated, 100% effaced, and +1 station, and pushing began. Intermittent variable and late decelerations occurred during pushing but resolved with maternal repositioning, with baseline FHR remaining approximately 150 bpm. The physician discussed vacuum assisted delivery multiple times, including at 12:44 PM, but determined at that time that fetal descent was insufficient for safe vacuum use. At approximately 14:00, decelerations reached nadirs in the 40-50’s for the first time, and the fetus was at +3 station with crowning. Due to significant caput but adequate ability to place the vacuum safely, the physician proceeded with vacuum assisted vaginal delivery as the most expeditious option. Vacuum assistance occurred over four contractions. The infant was delivered but was nonresponsive with no cry at birth; the cord was immediately clamped and cut, and the infant was transferred to the NICU team, who had been present during the final pushing efforts. The baby expired after resuscitative efforts failed. During review of the fetal heart monitoring strips for Patient #1 on 5/11/2026 at 12:00 PM, the Evidence Based Quality Coordinator (EBQC) stated regarding 04/22/2026 at 10:00 AM, the fetal heart monitoring strip showed minimal variability with no accelerations (abrupt, temporary increases in the baby’s heart rate above the baseline considered a reassuring sign that the fetus is healthy, well-oxygenated, and has a properly functioning nervous system), and the Pitocin was increased from 8 units to 10 units. At 10:30 AM, the fetal heart monitoring strip showed minimal variability, accelerations were absent, late and variable decelerations (specific patterns in a baby’s heart rate observed during electronic fetal monitoring during labor. They represent different underlying issues and require specific medical interventions) are present, and the Pitocin was increased from 10 units to 12 units. At 11:00 AM, the fetal heart monitoring strip showed minimal variability, accelerations are absent, late and variable decelerations are present, and the Pitocin was increased from 12 units to 14 units. At 12:00 PM, the fetal heart monitoring strip showed absent variability, accelerations are absent, late and variable decelerations are present; the Pitocin is still infusing. The EBQC stated that the nurses charting was not appropriate, and the use of Pitocin was not appropriate. The bedside nurse had fetal monitoring education and should be competent in reading an electronic fetal monitoring strip. She should be able to tell if a baby is in distress. Based on review of the strip, they did not follow the protocol. During an interview on 05/11/2026 at 9:36 AM, the Risk Manager stated no one identified the strip (fetal heart monitoring) looked bad, the strip prior looked ok. There were some variability (fluctuations in the baseline heart rate) and some variables (decelerations). Not repetitive late decelerations variability during pushing more repetitive variable (how well the baby is tolerating the physical stress of delivery). The MD (Medical Doctor) was at the bedside the whole time. The patient was not listening to be able to pause and check heart rate; that’s where the problem was. The patient was pushing with and without contractions so they could not make sense of the pattern due to her pushing constantly. The MD told me she felt the pattern was not unusual and often returned to baseline. The MD found it hard to define a moment where she would change the management of the patient. The case was sent for per review, and opportunities were identified and are being addressed. During an interview on 05/11/2026 at 1:34 PM, Patient #1’s beside RN (Registered Nurse) stated the MD ordered to start a low dose Pitocin and she said I’ll be back in two hour; there was a couple times baby heart rate went down, and we repositioned mom then baby heart rate came right back up. Patient #1 began pushing. The babies’ heart rate kept going down and the patient was getting erratic. The MD educated mom on using the vacuum (a procedure used during the second stage of labor. A doctor attaches a soft, plastic suction cup to the baby’s head to gently guide the baby through the birth canal while the mother pushes) to assist with the delivery. I’ve never had a provider use the vacuum that long. The patient was just screaming. At one point, the MD said to continue pushing and she was stepping out to check on another patient. I was not comfortable with that, so I went to get her and to tell her to come back and she needs to stay. A lot of people were in the room because the fetal heart strip (continuous visual record of a baby’s heart rate alongside the mother’s uterine contractions) looked bad meaning the baby’s heart rate kept dropping to the 90’s. Looking back on the situation, I should have gone to get another MD to help after the 1st hour of pushing and the frequent decelerations that were occurring. During an interview on 05/11/2026 at 2:12 PM, the MD stated when I did my morning rounds Patient #1 was still 6 centimeters and I said OK let’s increase her Pitocin and if she’s not able to progress then I plan on doing a section (a surgical procedure used to deliver a baby through incisions in the mother’s abdomen and uterus). She did progress and she had some intermittent (stops and starts at irregular intervals) decelerations throughout the day but always responded when we put her in different positions. I think the patient was completely dilated (your cervix has opened to 10 centimeters, allowing enough room for the baby’s head and shoulders to pass through the birth canal.) at 11:30 am and started pushing. There was a period when she requested I help her while she pushes. There was a brief period when I was out of the room, and I checked on the other laborers. She was pushing well and then she had a very deep variable that went to the 40’s and then the heart rate came immediately back up to the 150’s but without much variability at all, very minimal. When it did that again, it was down for 30 seconds or less. Then the next one was similar maybe 30 to a minute. I said “OK, I think we need to get the vacuum out.” The patient kept saying can you please help me? Can you do something to help me get this baby out faster? I was like it is not worth the risks of a vacuum at the point at which she was requesting help. Then at the point she had that really deep variable and if I had tried to do a section I was really concerned the baby would be wedged down the pelvis and I would have a very difficult extraction, or it would take longer like getting to the OR (operating room). I have never used a vacuum in my career. There were times when the baby had late decelerations but felt the baby was safe to be delivered vaginally. I think it was more cord compression during that time. The strip was category but able to do position change and the baby target rate would come back up. The Pitocin was not turned off because she was progressing, the baby was responding to position changes, and the baby did not show signs of distress for longer than 1 minute. We have a meeting coming up for women’s clinical institution and category 2 algorithm will be discussed. I’m not sure if we are discussing that because of the incident. During an interview on 05/11/2026 at 2:39 PM while reviewing the fetal heart monitoring strips, the Director of Women’s Services, who is certified in electronic fetal monitoring, stated based on the protocols, she would not have increased the Pitocin. The charting does not look accurate. The Pitocin should have been turned off. During an interview on 05/11/2026 at 3:39 PM, the CMO (Chief Medical Officer) stated during the peer review, it was identified that there were opportunities for strip interpretation and interventions that were not done. Until more discussions, the MD will not be able to practice here or at [another hospital name] until more discussions can take place.”

    Rule A0353. Standard-level. From a complaint.

All 2 inspections in the last three years
Inspections on record
DateVisitWhat the record says
May 11, 2026Complaint inspection2 deficiencies cited
Apr 29, 2025Complaint inspectionNo deficiencies cited

How do patients fare?

  • CMS’s overall for it is 4 of 5.
  • Of the measures behind its , CMS counts against the national value: mortality, 1 better and 0 worse of 8; safety of care, 2 better and 0 worse of 8; readmission, 1 better and 2 worse of 11.
  • Patients rate it 3 of 5 in CMS’s patient survey (4,626 surveys completed, Oct 1, 2024 to Sep 30, 2025): 78% rated it 9 or 10 out of 10, and 81% would definitely recommend it.
  • Infections, compared by CMS with the national benchmark (Oct 1, 2024 to Sep 30, 2025): central line bloodstream infections (CLABSI), better than the national benchmark; catheter urinary tract infections (CAUTI), no different than national benchmark; surgical site infections after colon surgery, no different than national benchmark; surgical site infections after abdominal hysterectomy, no different than national benchmark; MRSA bloodstream infections, no different than national benchmark; C. diff infections, better than the national benchmark.
  • CMS’s patient safety composite for serious complications, PSI 90, Jul 1, 2022 to Jun 30, 2024: no different than the national value.
  • Deaths within 30 days, as CMS gives them (Jul 1, 2022 to Jun 30, 2025): heart attack 11.2%, heart failure 12.2%, pneumonia 17.3%, COPD 11%, stroke 11.2%, heart bypass surgery 1.6%. CMS gives no comparison with the national rate for them in this release.
  • Readmissions within 30 days, as CMS gives them (Jul 1, 2023 to Jun 30, 2025): heart attack 14.6%, heart failure 22.2%, pneumonia 17.8%, COPD 20.7%, heart bypass surgery 8.7%, hip or knee replacement 5.9%. CMS gives no comparison with the national rate for them in this release.
  • After outpatient care, compared by CMS: unplanned hospital visits after a colonoscopy, no different than the national rate; hospital admissions after outpatient chemotherapy, no different than the national rate; emergency visits after outpatient chemotherapy, no different than the national rate; unplanned hospital visits after outpatient surgery, better than expected.
  • Emergency department patients spent a median of 181 minutes there before leaving (Oct 1, 2024 to Sep 30, 2025), and 2% left before being seen.
  • 78% of patients with severe sepsis or septic shock got the care CMS measures, SEP-1 (Oct 1, 2024 to Sep 30, 2025).
  • Medicare’s spending per patient here is 1.03 times the national median (Jan 1, 2024 to Dec 31, 2024).
Ratings and measures, as published
MeasureRating
Overall ratingCMS’s overall hospital quality star rating, 1 to 54 of 5
Patient survey ratingCMS star rating from its survey of the hospital’s patients (HCAHPS), 1 to 53 of 5

Is it certified, and in good standing?

  • Medicare-certified acute care hospital since Jul 1, 1966.
  • Ownership: voluntary non-profit - private.
  • It is accredited by The Joint Commission, whose surveys stand in for the state’s routine inspections.
  • No deficiency on record in the last three years.
  • Voluntary non-profit - Private.
Source:

CMS, Provider of Services File - Hospital & Non-Hospital Facilities. Released Oct 14, 2026. Updated quarterly.

CMS, Hospital General Information. Released Aug 13, 2026. Updated quarterly.

CMS, QCOR Hospital 2567 statements of deficiencies. Released Oct 20, 2026. Updated monthly.

Has it been penalized?

  • CMS doesn’t publish fines or other penalties for hospitals.
  • Not among the hospitals whose Medicare payments CMS cut under the Hospital-Acquired Condition Reduction Program for fiscal year 2026.
  • 2 deficiencies cited in the last three years came from inspections that included a complaint investigation.
Source:

CMS, Hospital-Acquired Condition (HAC) Reduction Program. Released Aug 13, 2026. Updated yearly.

CMS, Provider of Services File - Hospital & Non-Hospital Facilities. Released Oct 14, 2026. Updated quarterly.

CMS, QCOR Hospital 2567 statements of deficiencies. Released Oct 20, 2026. Updated monthly.

What do patients say about their care?

  • CMS doesn’t publish staffing levels for hospitals.
  • In CMS’s patient survey, patients rate how well its nurses communicated 4 of 5.
  • 35% of its health care workers got a flu shot (Oct 1, 2024 to Mar 31, 2025).
Source:

CMS, Patient survey (HCAHPS) - Hospital and Timely and Effective Care - Hospital. Released Aug 13, 2026. Updated quarterly.

Who owns it?

  • Baycare Health System, Inc. and Morton Plant Mease Health Care Inc. run it.
  • 20 owners or officers are people: Katherine E Cole (corporate director); Kimberly Guy (corporate officer); Patrice Muchowski (corporate director); Jorge P Navas (corporate director); David Almon Rood (runs it (operational or managerial control)); Kurt Erickson (corporate director); Michael Colletti (managing employee (on the payroll), 0%); Benjamin H Damsker (corporate director); Jennifer Buck (corporate director); Janice Sue Polo (runs it (operational or managerial control)); Susan Latvala (corporate director); Thomas P Inzina (runs it (operational or managerial control)); Marion Rose Rich (corporate director); Tina Joan Tenret (corporate director); Tonjua Williams (corporate director); Robert A Burwell (corporate director); Vincent Ferrara (corporate director); Robert J Entel (corporate director); Patricia Jones (corporate director); Robert G. Shaw (corporate director).
  • CMS’s Provider of Services file records 1 change of ownership.
  • No private-equity firm among the owners CMS lists.
  • No real-estate investment trust among the owners CMS lists.
Source:

CMS, Hospital All Owners and Hospital Enrollments. Released Sep 29, 2026. Updated monthly.

CMS, Provider of Services File - Hospital & Non-Hospital Facilities. Released Oct 14, 2026. Updated quarterly.

Organisations CMS lists
OrganisationRoleShareSince
Baycare Health System, Inc.Runs it (operational or managerial control)May 2, 2007
Morton Plant Mease Health Care Inc.Runs it (operational or managerial control)Mar 1, 2022

How does it compare nearby?

  • Of the 13 hospitals CMS lists in Pinellas County, 10 have an overall star rating from CMS: 4 rated 4 of 5, 2 rated 3 of 5, 3 rated 2 of 5, 1 rated 1 of 5.
  • CMS rates this one 4 of 5.
Source:

CMS, Hospital General Information. Released Aug 13, 2026. Updated quarterly.

What the record doesn’t say

  • CMS doesn’t publish fines or other penalties for hospitals, so none are shown. The one payment cut CMS publishes for each hospital, under its Hospital-Acquired Condition Reduction Program, is shown where it applies.
  • Only complaints that led to a citation appear; complaints that didn’t aren’t published.
  • Most hospitals are accredited by a private organisation (The Joint Commission, DNV and others) whose routine inspections stand in for the state’s; those reports aren’t public, and QCOR holds only the state’s surveys: no inspection on record here doesn’t mean none took place.
  • QCOR says its hospital inspection data are complete only through September 17, 2026, while it moves to a new system.
  • CMS doesn’t publish staffing levels for hospitals.
  • In its September 2026 release CMS gives no comparison with the national rate for death and readmission rates, though it gives the rates.

Sources

If you believe something here is wrong, a correction starts with the agency whose record this copies: CMS. CMS’s own record is on Care Compare. If Hearth Record copied something wrongly, it will fix it and log the correction publicly, with its date: how corrections work.

Source:

This copy of the record was made on Nov 5, 2026.

From the hospital

The public record above comes first. Anything the hospital adds will appear here, below it, and say who wrote it.

Replies

None. Replies aren’t open yet. When they open, the hospital will be able to answer any finding for free, and the reply will show beside that finding, unedited and dated.

Paid listing

None. Paid listings aren’t open yet. When they open, anything paid for will say “Paid by the hospital”, and paying will never change a finding, a rating or the order of results.

How to read a record

Four things every record does, shown on an example record made up for this guide.

An example record, made up for this guide

An example nursing home

Made up for this guide: no real place is shown

Not fully inspected in over two years (CMS flag)

11 health citations at the latest inspection cycle

The state average is 14.3.

Source:

CMS, State and US Averages and Health Deficiencies. Released Oct 28, 2026. Updated monthly.

From the homeNone yet. Replies and paid listings aren’t open, and when they open they will sit here, below the record.

1 of 4

Every fact names its source.

Who published it, when, and how often it changes sit beside each fact, with a link to the agency’s own file.

Sign in

A free account keeps your watch list, shortlists, comparisons and saved searches on every device, and can email you when something you watch changes. Browsing never needs one.